Skip to content

Squadron Capital Management LLC

Follow

13F filer, CIK 2050709, OAK BROOK, IL

Squadron Capital Management LLC reported $398,466,273 across 45 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 63.09% of the portfolio.

Accepted , ingested 13F-HR 0002050709-26-000036

Period
2026-09-30
Reported value
$398M
Holdings
45
Top 10 weight
63.09%
New
21
Sold out
19

Part of the filer group Squadron Capital Management LLC

  • Matthew Sesterhenn
  • Squadron Master Fund LP
  • William Blank
How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • TCXB TCGX ACQUISITION CORP II: 13G 650,000 shares, 5% of the class, 13G filed 2026-10-23, 0002050709-26-000028Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SLNnew+2,085,000$22.8M
ORICnew+1,000,000$13.5M
PHVSnew+400,000$12.7M
VERAnew+305,000$9.85M
DFTXadded+255,000$9.71M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
RLMDreduced-3,850,000-$14.5M
MAZEexited-335,000-$10M
ELVNexited-160,000-$8.12M
KODreduced-80,000-$7.58M
FBRXexited-225,000-$4.78M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0002050709-26-000036, largest first. % of portfolio is the value over $337,418,013, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 291,710 shares; 2026Q1: 380,000 shares; 2026Q2: 500,000 shares; 2026Q3: 420,000 shares 420,000$39.8M11.8%-80,000Timeline
CCCCC4 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 2,250,000 shares; 2026Q2: 7,200,000 shares; 2026Q3: 9,318,683 shares 9,318,683$31M9.2%+2,118,683Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 780,000 shares; 2026Q1: 787,492 shares; 2026Q2: 865,000 shares; 2026Q3: 915,000 shares 915,000$29.3M8.68%+50,000Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,085,000 shares 2,085,000$22.8M6.75%newTimeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 3,631,000 shares; 2026Q2: 3,700,000 shares; 2026Q3: 6,827,905 shares 6,827,905$18.9M5.61%+3,127,905Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 350,000 shares; 2026Q1: 350,000 shares; 2026Q2: 290,000 shares; 2026Q3: 425,000 shares 425,000$17.3M5.11%+135,000Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 672,500 shares; 2026Q2: 970,000 shares; 2026Q3: 785,000 shares 785,000$14.2M4.2%-185,000Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,000,000 shares 1,000,000$13.5M3.99%newTimeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 6,700,000 shares; 2026Q1: 8,474,571 shares; 2026Q2: 7,350,000 shares; 2026Q3: 3,500,000 shares 3,500,000$13.2M3.91%-3,850,000Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 85,000 shares; 2026Q3: 340,000 shares 340,000$12.9M3.84%+255,000Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 400,000 shares 400,000$12.7M3.76%newTimeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 1,265,231 shares; 2026Q2: 764,876 shares; 2026Q3: 764,876 shares 764,876$12.2M3.63%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 305,000 shares 305,000$9.85M2.92%newTimeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 300,000 shares; 2026Q1: 535,000 shares; 2026Q2: 2,435,000 shares; 2026Q3: 2,400,000 shares 2,400,000$8.86M2.62%-35,000Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 130,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000$6.9M2.04%newTimeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,200,000 shares 1,200,000$6.31M1.87%newTimeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 160,000 shares; 2026Q3: 225,000 shares 225,000$5.29M1.57%+65,000Timeline
ADAGADAGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,250,000 shares; 2026Q3: 1,616,618 shares 1,616,618$5.17M1.53%+366,618Timeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 350,000 shares 350,000$5.11M1.51%newTimeline
YARWYARROW BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 225,000 shares 225,000$5.07M1.5%newTimeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,200,000 shares 1,200,000$4.99M1.48%newTimeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 370,220 shares 370,220$4.63M1.37%newTimeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 260,000 shares; 2026Q3: 323,570 shares 323,570$4.34M1.29%+63,5702026-10-21, 13G: 1,700,000 shares, 5.1% of the class, 13G filed 2026-10-28 Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 4,225,000 shares; 2026Q1: 3,500,000 shares; 2026Q2: 3,000,000 shares; 2026Q3: 2,000,000 shares 2,000,000$4.11M1.22%-1,000,000Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 4,500,000 shares; 2026Q1: 3,000,000 shares; 2026Q2: 3,000,000 shares; 2026Q3: 3,000,000 shares 3,000,000$4.05M1.2%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 150,000 shares 150,000$3.74M1.11%newTimeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 215,000 shares 215,000$3.72M1.1%newTimeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 675,000 shares 675,000$3.48M1.03%newTimeline
IRLAQUINCE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 40,375 shares; 2026Q3: 90,000 shares 90,000$2.79M0.83%+49,625Timeline
JTTTJATT III ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 250,000 shares 250,000$2.75M0.82%newTimeline
SCYXSCYNEXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 756,884 shares; 2026Q3: 515,045 shares 515,045$2.54M0.75%-241,839Timeline
ALXOALX ONCOLOGY HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 1,460,000 shares; 2026Q2: not reported; 2026Q3: 1,400,000 shares 1,400,000$1.95M0.58%newTimeline
LPCNLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 530,000 shares; 2026Q1: 450,000 shares; 2026Q2: 810,000 shares; 2026Q3: 810,000 shares 810,000$1.78M0.53%0Timeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 600,000 shares 600,000$1.45M0.43%newTimeline
JATTJATT II ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 65,000 shares 65,000$731K0.22%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
KODKODIAK SCIENCES INC COMcall270,000$25.6Mnew
IRONDISC MEDICINE INC Stockcall134,500$8.8M+104,500
COGTCOGENT BIOSCIENCES INC COMcall265,000$8.49Mnew
RZLTREZOLUTE INC COMMON STOCKcall1,323,500$5.48M+423,500
AVBPARRIVENT BIOPHARMA INC COMcall142,500$4.31M-40,500
CTNMCONTINEUM THERAPEUTICS INC Stockcall225,000$3.02Mnew
SLNSILENCE THERAPEUTICS PLC ADScall180,000$1.97Mnew
BIOABIOAGE LABS INC Stockcall250,000$1.77M0
CCCCC4 THERAPEUTICS INC COM STKcall400,000$1.33M0
ZNTLZENTALIS PHARMACEUTICALS INC COMMON STOCKcall100,000$277K-326,000

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MAZEMAZE THERAPEUTICS INC335,000$10Mshares
ELVNENLIVEN THERAPEUTICS INC160,000$8.12Mshares
FBRXFORTE BIOSCIENCES INC225,000$4.78Mshares
IFRXINFLARX NV2,000,000$4.48Mshares
CMPSCOMPASS PATHWAYS PLC305,000$4.32Mcall
PMNPROMIS NEUROSCIENCES INC324,977$4.28Mshares
CMPSCOMPASS PATHWAYS PLC300,000$4.25Mshares
SLGLSOL-GEL TECHNOLOGIES LTD52,000$3.86Mshares
BIOABIOAGE LABS INC155,000$3.8Mshares
PRQRPROQR THRAPEUTICS N V1,511,496$2.81Mshares
RZLTREZOLUTE INC403,410$2.1Mshares
RAREULTRAGENYX PHARMACEUTICAL IN55,000$1.84Mcall
CUECUE BIOPHARMA INC50,000$1.58Mshares
CALCCALCIMEDICA INC1,244,864$1.28Mshares
NVCTNUVECTIS PHARMA INC38,700$712Kcall
KTTAPASITHEA THERAPEUTICS CORP1,000,000$515Kshares
INMINMED PHARMACEUTICALS INC325,000$504Kshares
NMRANEUMORA THERAPEUTICS INC.100,000$170Kshares
NXTCNEXTCURE INC64,464$103Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0002050709-26-000036 base2026-11-16